Ensuring Patient Safety with Mail Order Medications.

This bill's title ("Ensuring Patient Safety with Mail Order Medications") does not match its actual content. The bill, formally titled "AN ACT REVISING ABORTION-INDUCING DRUG LAWS," restricts the mailing of abortion-inducing drugs in North Carolina. It prohibits mailing such drugs to pregnant women unless a qualified physician provides in-person counseling 72 hours prior, all other informed consent requirements are met, and the drugs are FDA-approved. Violations carry $5,000 fines per offense or Class H felony charges, and the bill creates civil remedies allowing women, parents, or the Attorney General to sue for damages or injunctions. The bill is currently pending in committee (referred March 31, 2025) and would take effect December 1, 2025.